Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 9, 2026Thrombosis Research

Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Results of a European Delphi study

View Full Paper
Ask AI
Bookmark
Share

Authors

IMIsabelle MahéSHSkerdi HaviariInsermNMNassima Si Mohammed

Discussion

Loading...

Member takes

Implication

Delphi study develops a decision support tool for deprescribing antithrombotic therapy in end-of-life care, suggesting improved decision-making.

Key Points

  • The aim is to create a decision support tool for managing antithrombotic therapy in patients in end-of-life care.
  • Conducted a European Delphi study involving experts in end-of-life care and antithrombotic therapy.
  • Gathered consensus through multiple rounds of questionnaires.
  • Analyzed expert feedback to refine decision-making criteria.
  • Achieved consensus on key factors influencing antithrombotic therapy in end-of-life care.
  • Identified specific guidelines for when to continue or stop antithrombotic treatment.
  • Provided a structured approach for healthcare professionals to follow.

Cite This Study

Mahé et al. (2026) studied this question.

synapsesocial.com/papers/69613599766f0a95ea6adaeahttps://doi.org/10.1016/j.thromres.2025.109573
View Full Paper
Ask AI
Bookmark
Share